Population
In vitro and in vivo experimental models
Design
Preclinical
Follow-up
0 to 92 days
Authors
Loading...
Supports further preclinical refinement of the MagScrew TAH; leaves open clinical translation and human safety.
The MagScrew Total Artificial Heart demonstrated promising hydraulic performance and biocompatibility in early in vitro and in vivo testing.
Weber et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: